Carcinogen Progression Delay: GlutaBoost may play a role in slowing the progression of carcinogens, contributing to long-term wellness.*
The topological properties of the drug-disease network were analyzed using Cytoscape software, as demonstrated in Figure 5D
This treatment can include buprenorphine or methadone
A recent study entitled Elevation of glutathione as a therapeutic strategy in Alzheimers disease concludes: Increasing glutathione remains a promising therapeutic strategy to slow or prevent MCI and Alzheimers disease. Considering that glutathione levels continue to decline as we age, and that both AD and MCI increase with age, supplementation with effective glutathione can play an important role in prevention, or slowing the progression of this disease
This is supported by the observations that: (1) inorganic Hg accumulation in the proximal tubule region of the nephron is mainly handled by filtrationreabsorption as glutathione-Hg conjugates 5,6 , and (2) the renal uptake of glutathione-Hg conjugates occurs mainly at the luminal membrane via a molecular mimicry mechanism using animo acid transporters 9,12
This is why our standard antioxidant protocol at Silk Clinics is glutathione combined with vitamin C, rather than glutathione alone
